Literature DB >> 3139406

Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells.

E Meurs1, A G Hovanessian.   

Abstract

A clone of Daudi cells (Daudi-S) synthesizes the heavy chain of IgM (mu-chain) under routine conditions of cell culture. In the presence of alpha-interferon, however, synthesis of mu-chain is decreased rapidly at a time when the overall protein synthesis is not modified and the dsRNA-dependent protein kinase and the 2-5A synthetase are induced. This inhibition of mu-chain synthesis seems to be correlated with the antiproliferative action of interferon since it occurs only slightly in another clone of Daudi cells resistant (Daudi-R) to the antiproliferative action of interferon. In these resistant cells, however, the protein kinase and the 2-5A synthetase are induced by interferon. Specific inhibition of mu-chain synthesis in interferon-treated Daudi-S cells is a consequence of decreased steady-state levels of mu-chain mRNA. This effect occurs 4-8 h after addition of interferon in parallel with decreased levels of c-myc mRNA and enhanced levels of HLA mRNA. Reduced levels of mu-chain mRNA in interferon-treated Daudi-S cells is not a consequence of its enhanced degradation as shown by actinomycin D chase experiments. Furthermore, nuclear run on experiments rule out an effect on the transcription of mu-chain mRNA. Therefore, the inhibitory mechanism mediated by interferon might be at the level of termination and/or post-transcriptional processing of mu-chain RNA. In contrast, in these same interferon-treated Daudi-S cells, the inhibition of c-myc gene expression is due to an enhanced degradation of its mRNA (in accord with other reports). These data indicate that interferon can inhibit gene expression by different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139406      PMCID: PMC457154          DOI: 10.1002/j.1460-2075.1988.tb02997.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after Epstein-Barr virus conversion.

Authors:  L Montagnier; J Gruest
Journal:  Int J Cancer       Date:  1979-01-15       Impact factor: 7.396

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin mu chain.

Authors:  J Rogers; P Early; C Carter; K Calame; M Bond; L Hood; R Wall
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

5.  Molecular cloning of a human histocompatibility antigen cDNA fragment.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

7.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.

Authors:  D H Wreschner; T C James; R H Silverman; I M Kerr
Journal:  Nucleic Acids Res       Date:  1981-04-10       Impact factor: 16.971

8.  Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences.

Authors:  T H Rabbitts; A Forster; C P Milstein
Journal:  Nucleic Acids Res       Date:  1981-09-25       Impact factor: 16.971

9.  Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis.

Authors:  B Härfast; J R Huddlestone; P Casali; T C Merigan; M B Oldstone
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon.

Authors:  F Rosa; D Hatat; A Abadie; D Wallach; M Revel; M Fellous
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  9 in total

Review 1.  Immunological aspects of antiviral therapy.

Authors:  M Peters
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Comparison of IgE expression at the mRNA and protein levels in vitro.

Authors:  K J Turner; J Creany; R J Coelen; K J Cameron; B J Holt; M W Beilharz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  In vivo generation of 3' and 5' truncated species in the process of c-myc mRNA decay.

Authors:  P Ioannidis; M Havredaki; N Courtis; T Trangas
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

4.  Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.

Authors:  M D Maloney; B Binnington-Boyd; C A Lingwood
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

Review 5.  Post-transcriptional control of the interferon system.

Authors:  Khalid S A Khabar; Howard A Young
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

6.  Post-transcriptional regulation of transferrin receptor mRNA by IFN gamma.

Authors:  M F Bourgeade; F Silbermann; L Kühn; U Testa; C Peschle; S Mémet; M N Thang; F Besançon
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

7.  Mechanism of interferon action: alpha and gamma interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells.

Authors:  D C Thomas; C E Samuel
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.

Authors:  I C Oliveira; P J Sciavolino; T H Lee; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Cells resistant to interferon are defective in activation of a promoter-binding factor.

Authors:  D S Kessler; R Pine; L M Pfeffer; D E Levy; J E Darnell
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.